You are here

Flu

FDA grants fast-track status to combination mRNA flu and COVID-19 vaccine candidates

Beckers Hospital Review

Tue, 12/17/24 - 12:09 pm

Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza

Drugs.com

Tue, 12/10/24 - 10:02 pm

clinical trials

Cases hit pre-COVID lows as virus season begins

Axios

Thu, 11/14/24 - 10:00 am

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool

CP Wire

Thu, 10/10/24 - 03:23 pm

artificial intelligence

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool

Thu, 10/10/24 - 03:22 pm

artificial intelligence

Roche reports positive data from Phase III influenza treatment trial

Clinical Trials Arena

Thu, 09/19/24 - 09:24 am

clinical trials

GSK's mRNA flu vaccine finally overcomes tricky B strains in phase 2 trial

Fierce Biotech

Thu, 09/12/24 - 10:18 am

clinical trials

Pfizer, BioNTech's combo mRNA shot is latest to be defeated by influenza strain B

Fierce Biotech

Fri, 08/16/24 - 11:25 am

FluGen’s intranasal flu vaccine boosts flu shot efficacy

Clinical Trials Arena

Mon, 07/15/24 - 10:04 am

clinical trials

intranasal vaccines

GSK Pays $430M Upfront for CureVac’s COVID-19, Flu mRNA Vaccines

BioSpace

Wed, 07/3/24 - 11:25 am

Moderna receives $176 million from BARDA for mRNA influenza vaccines

Stat

Tue, 07/2/24 - 11:54 am

Moderna Therapeutics

Moderna’s COVID-Flu combo shot beats separate vaccines in phase III study

BioSpace

Mon, 06/10/24 - 11:27 am

Moderna Therapeutics

clinical trials

Sanofi forges $1.2bn alliance with vaccines firm Novavax

Pharmaphorum

Fri, 05/10/24 - 11:11 am

CureVac, chasing Moderna's mRNA flu vaccine, runs into the same B strain problems

Fierce Biotech

Thu, 04/4/24 - 11:24 am

Moderna Therapeutics

Don't count us out yet, Novavax says

Axios Health

Thu, 04/4/24 - 11:22 am

Moderna Secures Up to $750M in Funding from Blackstone to Advance Flu Program

BioSpace

Wed, 03/27/24 - 11:19 am

Moderna Therapeutics

GSK, Vir end flu drug alliance, removing key piece of $345M pact

Fierce Biotech

Fri, 02/23/24 - 10:30 am

Vir Biotechnology

monoclonal antibodies

WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge

Reuters

Fri, 01/12/24 - 09:45 am

Pfizer's mRNA flu vaccine hits primary goals in phase 3 trial, but secondary miss raises questions

Fierce Biotech

Tue, 10/31/23 - 10:15 am

clinical trials

Cidara’s J&J-partnered immunotherapy could target flu and cancer

Pharma Voice

Thu, 10/26/23 - 10:35 am

drug-Fc conjugates

Pages